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Abstract
Background: The core-group theory of sexually transmitted infections suggests that targeting prevention to high-risk
groups (HRG) could be very effective. We aimed to quantify the contribution of heterosexual HRGs and the potential impact
of focused interventions to HIV transmission in the wider community.
Methods: We systematically identified studies published between 1980 and 2011. Studies were included if they used
dynamical models of heterosexual HIV transmission, incorporated behavioural heterogeneity in risk, and provided at least
one of the following primary estimates in the wider community (a) the population attributable fraction (PAF) of HIV
infections due to HRGs, or (b) the number per capita or fraction of HIV infections averted, or change in HIV prevalence/
incidence due to focused interventions.
Findings: Of 267 selected articles, 22 were included. Four studies measured the PAF, and 20 studies measured intervention
impact across 265 scenarios. In low-prevalence epidemics (#5% HIV prevalence), the estimated impact of sex-worker
interventions in the absence of risk compensation included: 6–100% infections averted; 0.9–6.2 HIV infections averted per
100,000 adults; 11–94% and 4–47% relative reduction in prevalence and incidence respectively. In high-prevalence
epidemics (.5% HIV prevalence), sex-worker interventions were estimated to avert 6.8–40% of HIV infections and up to
564 HIV infections per 100,000 adults, and reduce HIV prevalence and incidence by 13–27% and 2–14% respectively. In both
types of epidemics, greater heterogeneity in HIV risk was associated with a larger impact on the fraction of HIV infections
averted and relative reduction in HIV incidence.
Conclusion: Focused interventions, as estimated by mathematical models, have the potential to reduce HIV transmission in
the wider community across low- and high-prevalence regions. However, considerable variability exists in estimated impact,
suggesting that a targeted approach to HIV prevention should be tailored to local epidemiological context.
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Introduction
The concept of behavioural heterogeneity and core-groups has
been critical to our understanding of how sexually transmitted
infections (STI) are transmitted and persist in a population [1,2,3].
Core-group theory implies that a relative few individuals are more
likely to become infected and disproportionately more likely to
transmit infections, such that in the absence of this heterogeneity
the STI epidemic could fail to establish and persist [2,4]. It has
therefore been suggested that epidemic control could be better
achieved by focusing interventions on high-risk groups (HRGs)
[5].
Behavioural heterogeneity often reflects the presence of a HRG
that consists of individuals who engage in multiple serial or
concurrent partnerships at a frequency greater than the rest of the
population. Sex work is one such example. Women and men who
sell sex have a larger number of sexual partners and in some cases,
due to social marginalization, they have less access to treatment or
even condoms to reduce infectivity [2]. Therefore, transmission is
high within commercial partnerships. Over time, infection moves
from this ‘core-group’ to a wider population through a ‘bridge’
population [2,6]. Commonly, this bridge comprises men who have
sex with sex workers and non-commercial partners. For hetero-
sexual STI epidemics, other sources of heterogeneity include
circular migration because of the potential for associated changes
in partnerships as individuals travel back and forth between home
and destination (for example, seasonal short-term migration for
work) [7,8,9], casual multiple partnerships, and other concurrent
partnerships outside of commercial sex.
Some countries have adopted a focused approach to HIV
prevention, and are targeting interventions to HRGs [5,10]. But in
other countries, particularly in sub-Saharan Africa, only a few
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regions are targeting interventions to HRGs such as female sex
workers (FSWs) [11,12]. Recent data suggests that HIV prevalence
among FSWs in Kenya and Uganda exceed 40% [13,14,15].
Earlier in the epidemic, more than 80% of FSWs working in
Nairobi were infected with HIV [16,17]. A paucity of data on the
presence and size of HRGs remains an obstacle to delineating the
role of HRGs in high-prevalence epidemics and to implementing
focused interventions in many regions of the world [18]. Insights
into the contribution of HRGs, particularly FSWs and clients, to
different HIV epidemics could help to inform HIV prevention
strategies [19].
By simulating counterfactuals (i.e. ‘‘what-if’’ scenarios), math-
ematical models provide a platform for the assessment of (a) the
contribution of HRGs to HIV transmission in the wider
community (herein referred to as ‘‘overall transmission’’), and (b)
the population-level impact of any one or a combination of
behavioural, biological, and structural interventions focused on
HRGs. In this study, we systematically review published dynamic
mathematical modelling studies of heterosexual HIV transmission
which measured the contribution of HRGs or the potential impact
of focused interventions. First, we summarize the model features,
populations, and time-horizon of impact assessment. We then
explore the potential sources of variability in model estimates
across simulations and present pooled estimates where possible.
Methods
We searched PubMed, MEDLINE, and EMBASE for studies
published between 1980 and 31 December, 2011. The search
included the following terms: (HIV* or AIDS [MeSH term or
abstract]) and (model*[keyword or abstract]) and (in all fields,
[‘‘math*’’ or ‘‘transmission’’ or ‘‘dynamic*’’ or ‘‘stochastic’’ or
‘‘compartment*’’ or ‘‘deterministic’’ or ‘‘agent-based’’ or (‘‘agent
based’’) or ‘‘individual-based’’ or (‘‘individual based’’) or’’
network*’’ or ‘‘simulation*’’ or (‘‘computer simulation*’’) or
‘‘micro-simulation*’’ or ‘‘discrete-time’’ or (‘‘discrete time’’) or
(‘‘discrete-event*’’) or ‘‘discrete event*’’]). There were no language
restrictions. Following the removal of duplicates, all titles and
abstracts were screened for exclusion. When a citation was
considered potentially relevant or the title/abstract was deemed
insufficient for a decision on inclusion or exclusion, the full text of
the article (and online supporting material or appendix) was
evaluated. One reviewer (SM) conducted the search and data
extraction.
Definitions and Inclusion/exclusion Criteria
A HRG consisted of one or more of the following subgroups:
FSWs; clients; men and women with casual or long-term multiple
(serial or concurrent) partnerships; circular migration or in-
migration associated with commercial sex, or with multiple
partnerships. A non-commercial high-risk group was restricted to
men and women with casual or long-term multiple partnerships.
Studies were included if they used dynamical models of
heterosexual HIV transmission, incorporated behavioural hetero-
geneity in HIV risk between individuals, and quantified the
population impact of either of the following primary outcomes: (1)
HIV transmission from a HRG to the wider community, or (2)
interventions focused on a HRG. For the first outcome, studies
were included if they measured the cumulative population
attributable fraction over t years (PAFt) of transmitted events
due to a HRG (fraction of incident infections in the wider
community that would fail to manifest in the absence of
transmission within and from a HRG). For the second outcome
(intervention impact), studies were included if they measured the
absolute number or fraction of new infections prevented (prevent-
ed fraction, PF), or the relative change in HIV prevalence/
incidence over any time-period. All types and combinations of
focused interventions were considered. Wherever possible, we
extracted outcomes measured in the total population (TP,
including the HRG). Outcomes in the general population (GP,
total population excluding the HRG) or in the female GP were
used if the first indicator was not available.
Mathematical models that did not incorporate a dynamical
relationship between prevalence and incidence, such as cohort and
static models were excluded. We excluded reviews without
primary modeling results, models in conference abstracts alone,
and unpublished studies, because their methodology and results
could not be comprehensively assessed.
To avoid confusion with the various definitions and use of the
terms ‘concentrated’ and ‘generalized’ epidemics [20,21], we
divided epidemic size into high-prevalence (current or endemic
HIV prevalence in the total or general population, or female GP,
.5%) and low-prevalence (current or endemic HIV prevalence in
the total or general population, or female GP, #5%).
Exploratory Analysis of Study Results for Sources of
Variability in Model Estimates
A single modeling study often includes outcomes from multiple
scenarios. Within a single study, scenarios could vary with respect
to epidemiologic and intervention-related assumptions. In order to
quantify the sources of variability in model outcomes, we
examined all scenarios (Ns) within each study (N). For each
scenario, we extracted primary outcomes, epidemiologic charac-
teristics, and intervention-related assumptions.
We summarized the different outcomes across studies in forest
plots stratified by epidemic characteristics, which allowed for a
visual assessment of sources of variability. If there were at least 15
scenarios that measured a primary outcome, we performed an
exploratory (hypothesis generating) analysis to describe influential
sources of variability in outcomes. First we assessed the univariate
fraction of variance explained by epidemiologic and intervention-
related assumptions. If a covariate explained .10% of the
variability in a given outcome, we explored its relative influence
on outcomes using the partial correlation coefficient across
scenarios which included FSWs and clients. The exploratory
analysis was performed separately for low- and high-prevalence
epidemics, and was restricted to the following primary outcomes:
relative reduction in HIV incidence, PF, and number of HIV
infections averted (for high-prevalence epidemics), due to focused
interventions. The following available covariates were considered
(table 1): epidemiologic characteristics (overall HIV prevalence,
epidemic phase, HIV prevalence in subgroups, ratio of HIV
prevalence between subgroups, type of HRG (FSW; FSW and
clients; FSW, client and non-commercial HRG; non-commercial
HRG), ratio of partner exchange rates between subgroups [risk
differential]); and intervention-related parameters (prevention tool,
coverage of HRG, efficacy in reducing HIV susceptibility per sex
act [or transmission probability if intervention effect on HIV
susceptibility was not differentiated from intervention effect on
HIV infectivity], time-horizon for outcome measurement). Table 1
lists the covariates which varied within studies.
We defined epidemic phase as ‘late’ if primary studies classified
their epidemic phase as ‘late’, ‘mature’, ‘plateau’, ‘peak’, ‘stable’,
‘endemic’, ‘endemic equilibrium’, or the HIV prevalence was
either declining or stable at the time of outcome measurement. All
other time points were classified as the ‘growth’ phase. Because the
primary study outcomes could be measured in different popula-
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tions (TP, GP, or female GP), analyses were adjusted for this
covariate.
We summarized primary outcomes by (a) tabulating the
estimated range across epidemic size, intervention-related model
assumptions, and type of HRG, and (b) pooling point estimates
from simulated scenarios for homogenous subgroups. Because
most studies did not provide an uncertainty range (or variance)
around point estimates for each simulated scenario, the pooled
estimates were un-weighted. Results are stratified by low- and
high-prevalence epidemics, unless otherwise stated. The analysis
was performed in Stata version 11 (StataCorp.).
Results
Characteristics of Studies
Our search criteria identified 18,726 citations, of which 1,642
were unique records (figure 1). Of 267 selected articles, 22 studies
were included for analysis.
Table 1. Intervention impact and covariates examined in the exploratory analysis for sources of variability in model outcomes.
HIV infections
averted per
100,000 adults
Fraction of HIV
infections averted
Relative change
in HIV incidence
Overall HIV prevalence .5% #5% .5% #5% .5%
N studies (of 20 which measured impact of focused intervention) 4 6 4 4 4
Ns scenarios (of 265** which measured the impact of focused intervention) 52 100 38 20 36
Covariates examined
Epidemiologic characteristics
Overall HIV prevalence ! !* !* !* !*
Ratio of HIV prevalence among FSWs to general population females !* !* !*
Ratio of HIV prevalence among clients to general population males !* !*
Ratio of number of clients to high-risk females ! ! !
Size of the FSW population (% of total adult females) ! ! !* !*
HIV prevalence among FSWs !* !* !*
HIV prevalence among clients !* !*
Risk differential among females: ratio of yearly partner exchange rate
(FSW to general population females)
! ! ! !*
Late phase compared with
growth phase (reference group)
!* !* ! !*
Intervention-related characteristics
Prevention tool * *
Condom use ! ! ! ! !
STI treatment ! ! !
Condom use & STI treatment ! ! ! !
Oral pre-exposure prophylaxis ! !
Oral pre-exposure prophylaxis & condom use !
Vaginal microbicide ! ! ! !
Vaccine ! ! !
Structural intervention (sexual violence) !
Intervention coverage of high-risk group !* !* !* !* !
Intervention efficacy*** !* ! ! ! !
Time-horizon for outcome measurement (years) ! ! ! !* !
Risk compensation versus no risk compensation !* ! ! ! !
High-risk group (HRG) *
FSWs ! ! ! ! !
FSWs and clients ! ! ! !
FSWs, clients, and non-commercial HRG ! ! !
Non-commercial HRG !
*Covariate varied within studies (as well as between studies).
**Number of scenarios (Ns) from the 20 studies (N), include scenarios which measured the relative change in HIV prevalence (Ns = 7), and the number of infections
averted in low-prevalence epidemics (Ns = 12). STI (sexually transmitted infection). FSW (female sex worker). Non-commercial HRG refers to individuals who engage in
multiple (non-commercial) partnerships.
***Efficacy in reducing HIV susceptibility per sex act (or transmission probability if intervention effect on HIV susceptibility was not differentiated from intervention
effect on HIV infectivity).
doi:10.1371/journal.pone.0050691.t001
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Figure 1. Results of search (PRISMA flow diagram) [43]. N refers to the number of studies. Among the studies that measured the outcomes of
interest, some could fall into more than 1 category. Note that a total of 144 studies were excluded because models were not dynamic.
doi:10.1371/journal.pone.0050691.g001
Focused HIV Interventions and Mathematical Models
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Table 2 summarizes the main model features of included
studies. Additional details are provided in the supplementary
tables (table S1, table S2). Most models were deterministic
(N= 21), and parameterized with region-specific epidemiological
and behavioural data (N= 19). Eleven models were calibrated to
observed HIV prevalence and used a single baseline parameter set.
The individual-based model analyzed different plausible epidemics
that agreed with observed HIV prevalence trends, but were
generated using one set of parameters [22]. Thus, this study took
account of random fluctuations in an epidemic rather than
parameter uncertainty [22]. Four studies employed a random
search of the parameter space to identify multiple parameter sets
that reproduced (‘‘fit’’) observed HIV prevalence data
[23,24,25,26]. These four studies conducted an uncertainty
analysis after fitting, whereas 13 of the remaining studies
conducted a sensitivity analysis (varying parameters without
refitting to data) to measure the influence of behavioural,
epidemiological, or intervention parameters (table 2).
The 22 studies focused primarily on epidemics in south India
and selected countries in sub-Saharan Africa (table S3). Commer-
cial sex interventions (in isolation or as part of interventions
targeted to non-commercial HRGs) were examined in 11 low-
prevalence epidemics, and in 9 high-prevalence epidemics (table 2).
Contribution of HRG to Overall HIV Transmission: PAF
Four studies measured the contribution of HRGs across 11
scenarios and over different time-horizons (figure 1, figure S1,
table S1). Therefore, we did not pursue further analysis to examine
the sources of variability in model estimates. In south India, the
estimated PAF1 of commercial sex (sex between FSWs and clients)
ranged between 86.4–97.5% in males and 12–42% in females
(N= 1) [23]. In the same region, the estimated contribution of
short-term client migration to overall transmission in the total
population was 50% over 34 years (PAF34) compared to 99% over
44 years (PAF44) under the assumption that local sex work
remained constant [27]. In other words, another male took the
place of a client who periodically left home [27]. In Zimbabwe, the
PAF20 of widowhood (assuming widows had a higher HIV
prevalence than the wider population and/or engaged in multiple
partnerships) ranged between 8 and 17% [28].
The contribution of migration to overall transmission was
complex, and was influenced by assumptions about the sexual
behaviour of migrants at home and away, as well as the sexual
behaviour of non-migrants while their partners were away. In the
Netherlands, if individuals who immigrated from high-prevalence
regions also engaged in high-risk sex locally, the PAF1 of in-
migration ranged between 22–53% [29].
Impact of Focused Intervention
Across 20 studies (figure 1), 265 scenarios examined a focused
intervention and measured the following outcomes: relative
change in incidence (Ns = 56); relative change in prevalence
(NS= 7); prevented fraction (Ns = 138); or number of infections
averted per 100,000 adults (Ns = 64). The time-horizon for
outcome measurement ranged from one year to an endemic
equilibrium which could take, in general, more than 20 years to
achieve (figure S2, figure S3, figure S4, figure S5).
Intervention impact varied considerably between studies (figure
S2, figure S3, figure S4, figure S5). The range of model estimates
(in the absence of risk compensation) is presented in tables 2 and 3,
and summarized across HRGs. In low-prevalence epidemics
(table 3), interventions targeted to FSWs in the absence of risk
compensation, were estimated to achieve the following: a PF
between 6–97% over 1–11 years [23,24,27,30] up to 100% (local
elimination) in the long-term [31]; a relative reduction in HIV
prevalence between 11–94% after 3–30 years [30,32,33,34]; a
relative reduction in HIV incidence between 4–47% after 1–10
years [23,32,35]; and the prevention of 0.9–6.2 HIV infections per
100,000 adults per year over 9 years [36].
In high-prevalence epidemics (table 4), interventions targeted to
FSWs in the absence of risk compensation, were estimated to avert
6.8–40% of new HIV infections over 20 years [30]; reduce HIV
prevalence by 13–27% over 10–30 years [30,33]; and reduce HIV
incidence by 2–14% over 1 year [26]. Two models estimated that
10 to 564 HIV infections could be averted per 100,000 adults per
year in high-prevalence epidemics following a commercial sex
intervention [26,36].
After stratifying by epidemic size and outcome, univariate
assessment of the fraction of variance explained by epidemiologic
and intervention-related characteristics (table S4), and subsequent
ranking of the partial correlation coefficients (figure 2), revealed
important sources of variability in model outcomes.
Sources of Variability: Epidemiologic Characteristics
Epidemiologic characteristics were important sources of vari-
ability for interventions simulated in both low- and high-
prevalence epidemics (table S4, figure 2).
In low-prevalence epidemics, the following epidemiologic
characteristics were influential sources of variability in the
estimated PF: the ratio of HIV prevalence in FSWs to general
population females, the ratio of HIV prevalence in clients to
general population males, size of the FSW population, ratio of
clients to FSW population size, and overall HIV prevalence
(figure 2a). In high-prevalence epidemics, a larger HIV prevalence
ratio between FSWs and GP females, and a larger risk differential
in partnership rates between FSWs and GP females were
correlated with a greater impact (figure 2b). The ratios of HIV
prevalence or partnership rates between FSWs and GP females
provide a proxy for the level of heterogeneity in the population.
Across epidemic size, a larger ratio was associated with a larger PF
(figure 2a–b).
Intervention impact on the PF was attenuated as overall HIV
prevalence increased in the low-prevalence epidemics (figure 2a).
This variability in intervention impact across geographically
‘similar’ epidemics was also observed within studies that examined
more than one district using the same model in south India
[23,24]. The same FSW intervention (treatment for STIs and
condom-use) was estimated to avert 20–25% of HIV infections in
Mysore (HIV prevalence in the female GP, 0.7%), but 10–12% of
infections in Bagalkot (HIV prevalence in the female GP, 2.2%)
over 5 years [24].
Four studies compared the impact of a focused intervention in
different countries. The findings highlight how the type of
outcome modifies the relationship between intervention impact
and epidemic size. STI-based interventions achieved a greater
impact in Benin (9% PF) as compared with a high-prevalence
scenario (19% PF in sub-Saharan Africa) [30]. The reduction in
HIV incidence after the introduction of a vaginal microbicide was
greater in Benin than in South Africa (27 to 29% relative
reduction versus 2.2 to 11.5% over 4 years) [25]. The same
condom-based intervention was estimated to achieve a 3-fold
greater reduction in overall HIV prevalence in India than in
Botswana [33]. However, as illustrated with oral PREP in
commercial partnerships (tables 2–3, figure S3), the absolute
number of new infections averted per capita was 100-fold greater
in larger epidemics [36]. In the absence of risk compensation, the
model estimated that for every 100,000 uninfected adults per year,
0.9–6.2 HIV infections could be averted in India over 9 years
Focused HIV Interventions and Mathematical Models
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[36]. Yet the same intervention was estimated to avert between
26–909 and 44–831 HIV infections per 100,000 uninfected adults
per year in Botswana and Kenya, respectively [36].
Sources of Variability: Intervention-related Characteristics
Variability in the type of prevention tool was not an important
source of heterogeneity in outcomes. Based on this analysis,
intervention coverage and efficacy were more influential than the
type of prevention tool (table S4).
In addition, the time-horizon for outcome measurement was an
important source of variability in estimated impact (table S4,
figure 2c). For example, in Benin, a program which could increase
condom use from 50 to 60% and treat 50% of gonorrhoea
infections in FSWs was estimated to prevent 22% of HIV
infections in 1 year, but 85% of HIV infections over 10 years
[30]. A focused intervention that increased condom use from 20–
45% to 80–100% and decreased bacterial STIs by 10% among
FSWs, was estimated to reduce HIV incidence by 10% after 5
years and by 35% after 10 years [37]. Intervention impact
increased over time because the direct prevention of a single case
of HIV by the intervention aborted all secondary transmission
events that would have taken place from that one case.
Risk compensation (modeled as an increase in risk-taking
behaviour among individuals who received an intervention) was
not an influential source of variability across scenarios (table S4),
but was influential within studies. Risk compensation was
examined for HIV vaccines, vaginal microbicides, and oral PREP
[25,35,36,38,39]. In a study examining oral PREP in India, if
FSWs and clients using PREP decreased condom use from 90% to
75%, the impact was attenuated from 6 fewer infections (no risk
compensation) to 17 more infections per 100,000 uninfected adults
[36]. In the case of HIV vaccines, 200 additional infections per
100,000 vaccinated adults were estimated to occur in the presence
of a 25–50% reduction in condom use if vaccines were (a) less
effective at reducing infectivity, and (b) provided to FSWs without
pre-screening for HIV [38]. None of the models examined risk
Table 3. Range of intervention impact, by outcomes measured in the wider community for epidemics with an HIV prevalence
#5%, in the absence of risk compensation.
HIV infections averted
per 100,000 adults*
Fraction of HIV
infections averted
Relative change in
HIV prevalence
Relative change in
HIV incidence
N studies 1 [36] 4 [23,24,27,30,31] 5 [30,32,33,34,48] 3 [23,32,35]
Epidemic phase
Growth – 7 to 100%ac 23 to 94%Qac –
Late 0.9 to 6.2c 6 to 50%ab 11 to 40%Qbcv 4 to 47%Qbc
Type of focused intervention (range of
% efficacy, range of % coverage)
Condom use (87–100, 20–100) – 13 to 100%abc 11 to 94%Qabcv 4 to 47%Qb
Condom use & STI treatment (70–100, 50–85) – 6 to 97%a 14 to 87%Qac –
Oral PREP (50–90, 25–50) 0.9 to 6c – – –
Oral PREP (50–90, 25–50), condom use (100,92.5) 2.7 to 6.2c – – –
HIV vaccine** (78,60) – – – 16.4 to 22.1%Qc
Anti-retroviral treatment (100,50) – – 23%Qc –
Coverage of high-risk group
,60% 0.9 to 3.3c 7 to 40abc – 16.4 to 22.1%Qc
$60% 3.3 to 6.2c 6 to 100%ac 11 to 94%Qabcv 4 to 47%Qb
Intervention efficacy**
,60% 0.9 to 3.3c 13 to 16%b – 4 to 22%Qb
$60% 3.3 to 6.2c 6 to 100%a 11 to 94%Qabcv 16.4 to 47%Qcb
Time-horizon (years)
1 – 6 to 40%a – 4 to 15%Qb
2–9 0.9 to 6.2c 7 to 25%ab 11 to 34Qbcv 5 to 47%Qb
10 – 14 to 97%a 40 to 78%Qac 16.4 to 22.1%Qc
.10 – 20 to 100%ac 25 to 94%Qac –
High-risk group (HRG)
FSWs 0.9 to 4.6c 6 to 100%abc 11 to 14%Qb 4 to 47%Qbc
FSWs and clients 1.8 to 6.2c 9 to 98%ab –
FSWs, clients, and non-commercial HRG – 22 to 86%a –
Non-commercial HRG – – 40 to 66%Qc –
Population in which the outcome was measured includes: alow-risk females; bgeneral population (excludes high-risk groups); ctotal population (includes high-risk
groups); vante-natal clinic attendees. Infections averted refer to the following: * per 100,000 uninfected adults (Vissers 2008 [36]). ** Efficacy in reducing HIV
susceptibility per sex act (or transmission probability if intervention effect on HIV susceptibility was not differentiated from intervention effect on HIV
infectivity).N = number of studies. STI (sexually transmitted infection). PREP (pre-exposure prophylaxis). Q(decline). FSW (female sex worker). Non-commercial HRG
refers to individuals who engage in multiple (non-commercial) partnerships.
doi:10.1371/journal.pone.0050691.t003
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compensation behaviour in the wider population as a result of an
intervention driven decrease in overall HIV prevalence, which
could potentially have a larger unwanted impact.
Impact of Focused Interventions: Summary Estimates
While the exploratory analysis yielded noteworthy patterns,
other potential factors, such as the nuances of interventions
(frequency of STI treatment, waning efficacy), were too few in
number to examine. Epidemiologic characteristics such as the level
of mixing between high- and low-risk groups were difficult to
standardize across studies. Summary estimates were therefore
limited to low-prevalence scenarios that measured the PF following
interventions targeted to FSWs (table 5), and could be pooled
across intervention efficacy in the absence of risk compensation. In
low-prevalence epidemics, FSW interventions with .60% efficacy
were estimated to avert a median of 20.5% (range, 7–43%) of HIV
infections in the wider community over the short-term (#5 years,
table 5, Ns = 12, N= 3), and a median of 59.0% (range, 40–100%,
Ns = 47, N= 3 ) in the long-term (.5 years).
Discussion
A small number of modeling studies demonstrated that
interventions focused on HRGs, particularly FSWs, could be
effective, even in high-prevalence epidemics. Notable themes
Table 4. Range of intervention impact, by outcomes measured in the wider community for epidemics with an HIV prevalence
.5%, in the absence of risk compensation.
HIV infections averted
per 100,000 adults
Fraction of HIV
infections averted
Relative change
in HIV prevalence
Relative change in
HIV incidence
N studies 3 [26,36,39] 3 [22,30,39] 5 [30,33,47,48,49] 3 [26,37,46]
Epidemic phase
Growth – 9 to 48%a 19 to 75%Qac 2 to 65%Qc
Late 10 to 14,617c*# 0.8 to 28.8%c 5 to 11%Qc 10 to 35%Qc
Type of focused intervention (range of
% efficacy, % coverage)
Condom use (100, 20–100) 10 to 14c# – 27 to 75%Qc –
STI treatment (50–100,20) 21 t o 44c# – – 14%Qc
Condom use & STI treatment (50–100, 20–100) 41 to 65c# 9 to 48%a 19%Qa 10 to 50%Qc
Vaginal microbicide (45,75) – – – –
Oral PREP (50–90, 25–50) 26 to 14,617c*# 0.8 to 28.8%c – –
Oral PREP (50–90, 25–50), condom use (100,62.5) 235 to 909c* – – –
Vaccine (78**, 100) – 5 to 18%c 5 to 11%Qc –
Anti-retroviral treatment (100,50) – – 13%Qc –
Partner reductionu (N/A,100) – – 8%Qc –
Structural intervention (sexual violence) (100,100) – – – 2 to 65%Qc
Coverage of high-risk group
,60% 10 to 419c*# 0.8 to 30%ac 5 to 19%Qac 13 to 14%Qc
$60% 251 to 14,617c*# 5 to 48%ac 8 to 75%Qc 2 to 65%Qc
Intervention efficacy**
,60% 26 to 419c*# 0.8 to 6.8%c 5 to 11%Qc –
$60% 10 to 14,617c*# 5 to 48%ac 8 to 75%Qac 2 to 65%Qc
Time-horizon (years)
1 10 to 65c# 9 to 30%a – 14%Qc
2–9 26 to 909c* – 8%Qc 10 to 50%Qc
10 5,356 to 14,617c# 0.8 to 48%ac 5 to 75%Qac –
.10 9 to 30%a 13 to 27%Qc 2 to 65%Qc
High-risk group (HRG)
FSWs 10 to 564c*# 6.8 to 40%a 13 to 27Qac 2 to 14%Qc
FSWs and clients 159 to 909c* 9 to 48%a – 10 to 50%Qc
FSWs, clients, and non-commercial HRG 5,356 to 14,617c# 0.8 to 28%c – –
Non-commercial HRG – – 5 to 75%Qc 2 to 65%Qc
Population in which the outcome was measured includes: alow-risk females; bgeneral population (excludes high-risk groups); ctotal population (includes high-risk
groups); vante-natal clinic attendees. uReduce partnership rate per year (among clients 20 to 15; among FSWs 400 to 50). **Efficacy in reducing HIV susceptibility per sex
act (or transmission probability if intervention effect on HIV susceptibility was not differentiated from intervention effect on HIV infectivity). Infections averted refer to
the following: *per 100,000 uninfected adults per year of intervention (Vissers 2008 [36]); (#per 100,000 adults per year of intervention (Abbas 2008 [39] and Vickerman
2006 [26]_ENREF_43_ENREF_43). N = number of studies. STI (sexually transmitted infection). PREP (pre-exposure prophylaxis).Q(decline). FSW (female sex worker). Non-
commercial HRG refers to individuals who engage in multiple (non-commercial) partnerships.
doi:10.1371/journal.pone.0050691.t004
Focused HIV Interventions and Mathematical Models
PLOS ONE | www.plosone.org 8 November 2012 | Volume 7 | Issue 11 | e50691
emerged from this analysis, including influential sources of
variability in reported outcomes across scenarios and studies.
Our review identified significant gaps in the literature: a limited
scope of epidemic types and regions have been explored to date,
both in the measurement of the contribution of HRGs and the
impact of focused interventions in the wider community. There
was insufficient information to derive summary estimates of the
contribution of specific HRGs to overall transmission, to
recommend one prevention tool over another, or to compare
the relative impact of focusing interventions on a given HRG
versus another. Nonetheless, our findings demonstrate key insights
for HIV prevention policies and the design of intervention
programs.
Factors which Influence the Estimated Impact of a
Focused Intervention
First, intervention impact was influenced by intervention
efficacy and coverage, and importantly, the time-horizon for
outcome assessment. Even with the rapid scale-up of a focused
intervention, it takes time to observe the impact of preventing
Figure 2. Tornado plot of the partial rank correlation coefficients. The coefficients range between 21 to +1, and indicate the relative
influence (and direction) of epidemiologic and intervention-related characteristics in contributing to the variability in model outcomes. Model
outcomes include: (a) the fraction of HIV infections averted in low-prevalence epidemics (#5%) following a focused intervention; (b) the fraction of
HIV infections averted in high-prevalence epidemics (.5%) following a focused intervention; (c) the relative reduction in HIV incidence in low-
prevalence epidemics (#5%) following a focused intervention; (d) the relative reduction in HIV incidence in high-prevalence epidemics (.5%)
following a focused intervention. All scenarios included FSWs and clients. FSW (female sex worker); GP (general population, does not include high-risk
groups). Efficacy refers to the % reduction in HIV susceptibility per sex act.
doi:10.1371/journal.pone.0050691.g002
Table 5. Summary estimates of the fraction of infections prevented in the wider population, when interventions were focused on
FSWs, in the absence of risk compensation.
Median prevented fraction (range, Ns), HIV prevalence #5%
Time-horizon for outcome assessment #5 years Time-horizon for outcome assessment .5 years
Intervention efficacy$60%* 20.5% (7 to 43, Ns = 12
a) [24,30] 59.0% (40 to 100, Ns = 47
ac) [27,30,31]
Population in which the outcome was measured includes: alow-risk females; bgeneral population (excludes high-risk groups); ctotal population (includes high-risk
groups); vante-natal clinic attendees.STI (sexually transmitted infection). Ns refers to the number of simulated scenarios. Summary estimates reflect the median and
range if $5 scenarios across at least 2 studies were available within each category. Estimates were grouped across intervention-related characteristics. *Efficacy in
reducing HIV susceptibility per sex act (or transmission probability if intervention effect on HIV susceptibility was not differentiated from intervention effect on HIV
infectivity). FSW (female sex worker).
doi:10.1371/journal.pone.0050691.t005
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secondary or indirect transmission events (infections among
persons who did not directly receive the intervention) [30,37].
As a result, short-term evaluations by HIV prevention pro-
grammes may underestimate the impact of focused interventions
[30,37].
Second, within each given focused intervention explored, the
estimated impact varied considerably by epidemiologic context.
Even within low-prevalence scenarios, and after grouping accord-
ing to intervention-related characteristics, the PF varied by nearly
50%. Residual variability was due in part to epidemiologic
characteristics (such as the difference in partnership rates and HIV
prevalence between subgroups, size of the FSW population, and
baseline HIV prevalence). Hence, even after stratifying by
epidemic size, the estimated impact of a focused intervention is
likely to vary by differences in epidemiologic characteristics. This
finding has important policy implications. Categorizing regions by
overall HIV prevalence alone [20] will be insufficient for making
decisions about whether or not to prioritize focused interventions.
Generalizability of model outcomes from one region to another
will depend on the extent to which (a) we understand the HIV
epidemic in the latter, and (b) the two regions have similar
epidemiologic characteristics. Empirical data confirms how
variable regions are with respect to heterogeneity in HIV risk
[15] as well as the size and behavior of sex worker populations
[18,40]. The relative risk of HIV in FSWs (compared with females
in the general population) range from 3.4 to 67.4 in sub-Saharan
Africa, and from 0.8 to 54.3 in Asia [15]. Hence, the findings from
this review suggest that focused interventions should be tailored to
the local epidemiologic context.
Third, interventions targeted to FSWs were effective in both
low- and high-prevalence epidemics. When the prevented fraction
was measured, intervention impact was larger in low-prevalence
scenarios. In contrast, the per capita infections averted was 100-
fold greater in magnitude in sub-Saharan Africa compared with
India, although this important insight was obtained from only one
study [36]. The issue of FSW (with or without client) interventions
in high-prevalence epidemics is important [19]. At present, sex
worker interventions are not widely applied in most high-
prevalence countries [11,12,41]. The findings from this review
suggest that interventions focused on FSWs could have an
important role to play in high-prevalence (often called ‘general-
ized’) epidemics.
As policy-makers design prevention policies in response to their
local HIV epidemic, these three issues will be important to
consider, in addition to the pragmatic issues of identifying and
reaching HRGs.
Knowledge Gaps
However, if we are to tailor a combination of interventions
according to local epidemiological characteristics, it will be critical
to understand the potential role of focused interventions across a
larger range of epidemics, prevention tools, and HRGs. The
contribution of HRGs, particularly FSWs and clients [19], and the
preventive potential of focused interventions remains under-
researched in high-prevalence settings. Additional studies (and
within-study scenarios) of prevention tools are required to estimate
the comparative effectiveness of different intervention packages
across epidemiologic context, and by focusing on different HRGs.
The potential impact of targeting HRGs for anti-retroviral
treatment [33] as prevention (differentiated from treatment for
individual benefit) also requires further study.
The level of evidence garnered from models depends on the
objective of the study. Modeling studies that aim to provide
qualitative, illustrative, or fundamental insights are distinguished
from region-specific, predictive [42] modeling studies that intend
to directly guide intervention programming. The latter should
include region-specific data for model parameterization, a
calibrated or fitted model to observed outcomes, and an
uncertainty or sensitivity analysis that examines the influence of
parameters on estimated outcomes. We found that 16 studies met
the above criteria. However, only 4 recent studies took into
account parameter uncertainty by using multiple calibrated
parameter sets instead of one baseline parameter set
[23,24,25,26]. A single parameter set may lead to overly optimistic
or pessimistic estimates, whereas the use of multiple calibrated
parameter sets allows for parameter uncertainty by providing a
range of plausible outcomes. Multiple fits also enable us to assess
which parameters have the greatest influence on estimated
outcomes.
Therefore, further study is needed into different combinations of
interventions within a targeted approach, in different epidemio-
logic contexts, focused on different HRGs, and with the use of
multiple calibrated parameter sets. Existing and new models could
help address these gaps.
Limitations
To date, there are no standard reporting guidelines for
systematic reviews of mathematical modeling studies, and we
therefore followed guidelines developed for empirical studies [43].
Previous modeling reviews have been mostly narrative [44,45]. We
have tried to make our review as quantitative as possible, as well as
assess study quality. The considerable variability between
published models provided important insights in the exploratory
analysis, but also limited our ability to derive pooled summary
estimates or to provide comparative estimates of intervention
impact by type of prevention tool. Pooled estimates were restricted
to 2–3 studies for interventions targeted to FSWs. Our findings are
also limited because many regions and prevention tools remain
under-researched. While we detected a positive correlation
between intervention efficacy and coverage, there was insufficient
data to suggest which prevention tools were most effective (after
controlling for other epidemiologic and intervention-related
sources of variability). It is important to note that our analysis
for influential sources of variability on model outcomes was
exploratory in nature, and was performed similar to a sensitivity
analysis. If covariates did not vary considerably between scenarios,
they were unlikely to emerge as an important source of variability
in model outcomes. We did not explicitly account for within-study
correlation of epidemiologic and intervention-related characteris-
tics, because our objective was restricted to a descriptive analysis.
Yet as we found in this review, there is a great potential for
synthesis of modeling studies. As illustrated in the search matrix
(table S3), studies to date preclude a region- or intervention-
specific synthesis of HRG contribution or focused intervention
impact, especially by different HRGs. As regional and outcome
gaps are addressed, a critical and quantitative synthesis will greatly
improve our use of model-based evidence. Comparative modeling
reviews could become particularly useful and important for policy-
makers as different models in different epidemiologic contexts are
used to answer the same questions (much like with empirical
research).
Conclusions
Modeling studies demonstrate that short-term evaluations could
underestimate the potential impact of interventions prioritized to
HRGs. The modeled impact of focused interventions across
epidemiologic context underscores the importance of understand-
ing local heterogeneity in HIV risk – a process that requires
Focused HIV Interventions and Mathematical Models
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estimating the size of HRGs (such as FSWs) and their relative risk
of HIV. Despite their infrequent application in practice
[11,12,41], focused interventions (including interventions targeted
to FSWs) could be effective in high-prevalence epidemics. Further
study is needed into the contribution of HRGs (particularly FSWs
and clients) in many under-researched regions with a high burden
of HIV.
Supporting Information
Figure S1 Contribution of high-risk group (HRG) or
behaviours to overall HIV transmission. Contribution is
measured as the population attributable fraction (PAF, %) of new
infections due to a HRG. Study estimates (diamond) and/or the
range of within-study estimates are shown for different HRGs and
by epidemic phase, and by epidemic size (overall HIV prevalence
#5% [black], and HIV prevalence .5% [blue]).The PAF was
measured in the total population with the exception of Vickerman
2010 [23]. FSW (female sex work) and client migration refers to
circular migration. *Client migration associated with more sex
work (sw) refers to an increase in the number of local men who pay
for sex when migrant clients are away. **Widowhood in the
context of a high-prevalence epidemic where HIV prevalence
among widowed men and women was 54% and 61%, respectively,
and widowed individuals engaged in high-risk sexual partnerships
(a larger number of partnerships and preferential mixing with non-
widows to preferential mixing with other widows) [28].
(PDF)
Figure S2 Prevented fraction (%) following a focused
intervention. Prevented fraction depicted for various types of
intervention, by an aggregate of coverage and efficacy (coverage
multiplied by efficacy), and time-horizon for the outcome
measurement (years) within studies. Study estimates (diamond)
and/or the range of within-study estimates are shown by epidemic
size (overall HIV prevalence #5% [black], and HIV prevalence
.5% [blue]). Efficacy refers to the reduction in HIV susceptibility
per sex act (or transmission probability if intervention effect on
HIV susceptibility was not differentiated from intervention effect
on HIV infectivity). *Risk compensation (Abbas 2007) was
modeled as a doubling in the number of partners per year among
individuals who received the targeted intervention [39]. *Risk
compensation (Vickerman 2006) was modeled as a 5% decrease in
baseline condom use (set at 85%) [25]. A vaccine that reduces HIV
susceptibility by 78% in the first year with a waning immunity
thereafter, repeated every 2 years (**), or every 5 years (***)[22].
STI refers to bacterial sexually transmitted infections.
(PDF)
Figure S3 The number of HIV infections averted per
100,000 adults per year after the implementation of a
focused intervention. Impact depicted for various types of
intervention, by an aggregate of coverage and efficacy (coverage
multiplied by efficacy), and time-horizon for the outcome
measurement (years) within studies. Study estimates (diamond)
and/or the range of within-study estimates are shown by epidemic
size (overall HIV prevalence #5% [black], and HIV prevalence
.5% [blue]). *Presence of risk compensation. Efficacy refers to the
reduction in HIV susceptibility per sex act (or transmission
probability if intervention effect on HIV susceptibility was not
differentiated from intervention effect on HIV infectivity).
Commercial sex work includes interventions focused of FSWs or
FSWs and clients. The results of a vaccine study are not shown in
this forest plot because outcome was measured as infections
averted per 100,000 adults who received the intervention [38].
**Vissers 2008 (per 100,000 uninfected adults per year) [36];
Vickerman 2006, Abbas 2007 (per 100,000 adults per year)
[26,39]. STI refers to bacterial sexually transmitted infections.
(PDF)
Figure S4 Reduction in prevalence (%) following a
focused intervention. Impact depicted for various types of
intervention, by an aggregate of coverage and efficacy (coverage
multiplied by efficacy), and time-horizon for the outcome
measurement (years) within studies. Study estimates (diamond)
and/or the range of within-study estimates are shown by epidemic
size (overall HIV prevalence #5% [black], and HIV prevalence
.5% [blue]). Efficacy refers to the reduction in HIV susceptibility
per sex act (or transmission probability if intervention effect on
HIV susceptibility was not differentiated from intervention effect
on HIV infectivity). **Overall prevalence was measured in the
antenatal clinic population. STI refers to bacterial sexually
transmitted infections. ART refers to combination anti-retroviral
treatment.
(PDF)
Figure S5 Reduction in incidence (%) following a
focused intervention. Impact depicted for various types of
intervention, by an aggregate of coverage and efficacy (coverage
multiplied by efficacy), and time-horizon for the outcome
measurement (years) within studies. Study estimates (diamond)
and/or the range of within-study estimates are shown by epidemic
size (overall HIV prevalence #5% [black], and HIV prevalence
.5% [blue]). Efficacy refers to the reduction in HIV susceptibility
per sex act (or transmission probability if intervention effect on
HIV susceptibility was not differentiated from intervention effect
on HIV infectivity). *Risk compensation in Vickerman 2006 was
modeled as a decline in condom use from 85% to 80% among
those who use the microbicide [25]. Risk compensation (Nagelk-
erke 2011) modeled as a decline in condom-use from 70% to 50%
among those who receive the vaccine [35]. STI refers to bacterial
sexually transmitted infections.
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